Canada markets close in 5 hours 13 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.07+0.64 (+6.83%)
As of 10:46AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,130
2,130
1,069
0
0
Operating Expenses
Research Development
215,519
215,519
179,289
127,026
65,030
Selling General and Administrative
50,072
50,072
49,736
38,297
18,250
Total Operating Expenses
265,591
265,591
229,025
165,323
83,280
Operating Income or Loss
-263,461
-263,461
-227,956
-165,323
-83,280
Total Other Income/Expenses Net
-20
-20
-181
159
1,925
Income Before Tax
-245,738
-245,738
-221,102
-165,164
-81,355
Income Tax Expense
678
678
0
0
-
Income from Continuing Operations
-246,416
-246,416
-221,102
-165,164
-81,355
Net Income
-246,416
-246,416
-221,102
-165,164
-81,355
Net Income available to common shareholders
-246,416
-246,416
-221,102
-165,164
-81,355
Basic EPS
-4.90
-
-5.32
-4.93
-2.65
Diluted EPS
-4.90
-
-5.32
-4.93
-2.65
Basic Average Shares
48,402
-
41,544
33,480
30,748
Diluted Average Shares
48,402
-
41,544
33,480
30,748